Google Chrome
Safari
Firefox
Edge
Search
Continuous Tableting for Drug Product
Hovione´s pragmatic approach to bridging science with manufacturing is now being leveraged for continuous tableting and it is the key to ultimately providing high quality medicines and the success of your drug product.
Press Release / Aug 23, 2022
Zerion Pharma and Hovione extend partnership to cover use of the Dispersome® technology platform in nutraceuticals
Hovione today announced an extension of collaboration on Zerion’s Dispersome® technology into the nutraceutical/dietary supplements field.
Press Release / Sep 19, 2024
Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions
Commitment to partnership and joint innovation for cell and gene therapies
Press Release / Sep 20, 2019
Hovione announces successful end-of-phase 2 meeting with the FDA and outlines phase 3 program for minocycline topical gel
Hovione announced details of its planned MARS-2 and MARS-3 (Minocycline Against Rosacea Study) Phase 3 development program for the treatment of moderate to severe inflammatory rosacea.
Press Clipping / Jun 21, 2021
Hovione meets increased demand during Covid
Irish Examiner, 21 june 2021
Hovione Capacity Expansion
Hovione is Growing
Press Release / Sep 23, 2020
Hovione Announces Partnership to Support Manufacturing of Antiviral Veklury® for COVID-19
Hovione today announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®